Multi-parameter flow cytometry is a powerful analytical tool, enabling rapid measurement of multiple, physical and chemical characteristics of individual cells. Examples of clinical applications of flow cytometry analysis are the measurement of minimal residual disease (MRD) in leukemia, inflammatory disease and the effect of biologicals. While flow cytometry has become more advanced, the interpretation of information is still complicated and time consuming for clinicians, technicians and researchers. Radboud University Nijmegen, together with UMC Utrecht, has developed an algorithm able to process raw data and filter disease-specific outcomes, by comparing the patient data with a healthy population, making diagnosis easier and faster. Moreover, increased precision means the number of false negatives will be reduced, allowing for an early cancer intervention.
Recent news
TherageniX and University of Nottingham Awarded £995K
TherageniX and University of Nottingham Awarded £995K Innovate UK Grant to Develop Powdered Gene Therapy for Bone Regeneration – Novel non-viral gene delivery…
Read more
IPD secures funding of €2.1M to initiate its first-in-human trials for prosthetic joint infections
PRESS RELEASE Amsterdam, July 20, 2023 IPD B.V. (Implant Preservation Devices), a Netherlands-based start-up specializing in the treatment of prosthetic joint infections, raised €2.1…
Read more
NLC and Australia’s BioCurate announce Strategic Alliance for Commercialization of New Therapies
Amsterdam, July 19, 2023 The two will collaborate on development projects to bring new therapies to market. NLC, the European Healthtech Venture Builder based…
Read more